IBE is looking for tester(s) to run log(s) for our Oratropin (cell mediated IGF-1 LR-3) and Hexatropin (GHRP-6 + Hexarelin) products. First, I will give an introduction to each product;
Oratropin - Cell mediated IGF-1 LR-3; subuccal delivery system, with 100% bioavailability. Subuccal delivery means that it is put in the mouth and absorbed by the cheek and the gums. It's a great alternative to the other method of administration of IGF-1 LR-3, since it provides the same amount of absorption, and is painless. The tester(s) will be receiving some of our new Oratropin; 80mcg per doser, allowing the tester flexability. What this new dosing means, is that the buyers will be able to twice as much Oratropin at once, with less cost to them ($70 savings off of buying two kits).
(written by LakeMountD)
There are many various types of MGF, MGF+IGF-1, IGF-1 stacks that have been attempted and although many of them have been successful, there hasn’t, yet, been a standalone winner. This is due to many factors including availability, price, and little experimental evidence on topics such as down regulation of receptors, antibody production, and suppression of natural hormones/growth factors. There are a lot of people on various boards attempting to “figure out” the scattered scientific data that is spread throughout the internet but it is doing only a small amount of good since most studies conducted on MGF and IGF-1 are done on rats and almost all of the studies done using IGF-1 use rhIGF-1, which mimics the naturally occurring growth factor. There are a lot of doctors and users who question the safety of exogenous IGF-1 use, however. The prime reason surrounding this questionability is due to the fact that IGF-1 has been shown to increase the growth rate of cancerous tumors, enlargement of organs, and various other lurking variables. It must be noted, however, IGF-1 does not directly cause cancer, however, if a cancerous cell culture is already forming then IGF-1 can increase the rate of growth.
In your body IGF-1 is spliced into many different variants that have different anabolic properties. IGF-1Ea and Mechano Growth Factor (IGF-1Ec or MGF) make up the more important spliced variants of the IGF-1 when referring to muscle growth. IGF-1 receptors are increased greatly following exercise due to lactosis (lactic acid buildup from resistance training), which causes muscle damage to the area. The lactic acid is currently thought to be the culprit as well for other irregular spliced variants of IGF-1, such as des 1-3 IGF-1, which is said to be 10 times more potent than that of IGF-1Ea. The most common variant seen in bodybuilding is Long Chain R3 IGF-1 or LR3 IGF-1. This is because LR3 IGF-1 cannot be bound to the IGF-1 Binding Protein 3 (IGF-1 BP3). IGF-1 and IGF-1 BP3 levels are released based off circulating levels of each. As concentrations of IGF-1 in the body rise so do IGF-1 BP3 and as IGF-1 concentrations fall so do IGF-BP3 levels. Recent scientific evidence points out that the reason for IGF-1 BP3 levels rising due to increased levels of IGF-1 is to increase the half-life of circulating IGF-1. Unbound IGF-1 has a half life of around 20 minutes, where as when it’s bound to IGF-1 BP3 the half life is extended to around ~6-12 hours depending on who you ask. This is why there is so much excitement surrounding LR3 IGF-1, since the effects can be seen at much lower dosages than rhIGF-1 due to the longer circulating half life and higher potency.
Although the exact pathways for muscle growth through the IGF-1 axis aren’t directly known or fully understood, a basic understanding has been established and common mechanisms are currently being discovered. Although the pathways go into a great deal of detail we will be sticking to the main IGF-1 and spliced variant pathways and not into MyoD or M-Cadherin related material/gene expression. It is thought that following muscle damage, circulating levels of IGF-1 are partially spliced towards MGF, which in turn proliferates (increasing in amount) myoblasts, which are stem cells that are used for creating muscle fibers. Muscles do not undergo mitosis like other cells, instead they must have myoblasts fuse to the area and be activated (given an identity). As seen in the graph below MGF levels are at their peak 1-2 days following muscle activity and begin to decline rapidly afterwards. IGF-1Ea levels begin to rise at the same time MGF levels begin to fall rapidly, around day 4. MGF proliferates cells in their mononucleated states (muscle stem cells), which is an important piece of the recovery puzzle since without these new stem cells there can be no new growth. This is seen in people with muscular dystrophy and although their bodies still produce IGF-1, their muscles do not exhibit MGF expression, showing the importance for MGF in recovering damaged muscles. Although MGF does proliferate these new stem cells as well as increase protein synthesis to a slight degree, MGF also inhibits differentiation in muscle cells (differentiation can be defined as: myoblast alignment, elongation, and fusion into multinucleate myotubes, basically giving them a new identity). IGF-1Ea completes the repairs by drastically increasing protein synthesis and differentiating these newly brought stem cells. Another possibility for IGF-1 is muscle hyperplasia. Although hypertrophy, which is seen with AAS usage and normal training, is the enlargement of the muscle fiber, due to maturing myofibrils within, while hyperplasia is the actual increase in muscle fibers (refer to Figure 8 below to see a picture). Hyperplasia will not be discussed in detail in this manual until it is more fully understood given scientific evidence based off of studies conducted by trusted scientists. Although many have stated that hyperplasia is impossible without exogenous use of IGF-1, this is a somewhat false statement; a better statement would be that IGF-1 induced hyperplasia occurs at a VERY slow rate naturally since at any given time less than 1% of all IGF-1 circulating in the blood is unbound from IGF-1 BP3. One must also know that despite IGF-1’s effects on muscle hyperplasia and the increased rate at which it occurs when using exogenous LR3 IGF-1, the overall results that are seen can often be seen at their greatest a fair amount of time after using LR3. This occurs due to the fact that newly made muscle fibers are not matured instantly during the process of hyperplasia. Instead, these cells must go through the process of hypertrophy before they mature and become enlarged, another exciting reason to use a combination of MGF and LR3 IGF-1. This is the process of body recomposition that people talk so much about on bodybuilding forums throughout the internet, as you can technically work around your genetic limit and move past it. It must also be noted that in recent studies caloric restriction had no significant effect on MGF, IGF-1, or IGF-1Ea (systemic, liver form of IGF-1) receptor count, making the possibility for exogenous LR3 IGF-1/MGF as a potent, muscle sparing cutter, a great idea.
Hexatropin - This is cell mediated as well, with the same delivery system. Each doser contains 100mcg of GHRP-6 and 100mcg of Hexarelin. Both of these release hgh.Hexatropin-6 is a combination of 2 peptides known to be analogues/agonists of Ghrelin, potent GH increasing agents, appetite stimulants, etc.
Cell-MediatedTM GHRP-6 and Hexarelin
(for oral use)
100% Bioavailability, Sustained 24-48 hours
Each kit contains:
2.0mg Cell-MediatedTM GHRP-6
2.0mg Cell-MediatedTM Hexarelin
20 individually sealed oral syringes for easy daily
dosing, no measurements, no hassles.
Each oral syringe contains:
100mcg Cell-MediatedTM GHRP-6
100mcg Cell-MediatedTM Hexarelin
0.5 cc's (0.661g) EctoTropin-6TM
GHRP-6 is a synthetic hexapeptide, which specifically releases growth hormone (GH) in a wide variety of species in vivo and in vitro. This peptide has been clinically verified to increase GH levels, increase appetite, raise IGF-1 levels, help sleep cycles and more. GHRP-6 duplicates the way the growth hormone works in the body. In studies it not only has shown to enhance growth hormone levels, but also increased the pulsatile secretion the bursts of GH. Another remarkable trait of GHRP-6 is its increase in normal pulsatile physiological secretion by its hypothalamic action.
Why did we add Hexarelin? Like GHRP-6, hexarelin is a six-amino acid peptide that significantly releases growth hormone. Studies have shown that hexareln is actually more effectiveand longer lasting than growth hormone releasing hormone (GHRH). It is known that GHRP-6 has a synergistic effect with GHRH, causing a fargreater release than either of these substances alone. By combining GHRP-6 with Hexarelin, we have created a more potent GH releasing peptide combination than ever heard of. The potential clinical usefulness of these GH releasing hexapeptides is also reinforced by observations that long-term administration produces elevations in circulating IGF-1 concentrations. Long term treatment with GHRP-6 similarly has been shown to elevate serum IGF-1 as well as IGF-binding protein-3 concentrations, alter body composition and promote linear growth.
Results 1 to 13 of 13